| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/22/2010 | WO2010028259A3 9-aminonoscapine and its use in treating cancers, including drug- resistant cancers |
| 07/22/2010 | WO2010022196A3 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1h-indol-3-yl]-methanone as an inhibitor of mast cell tryptase |
| 07/22/2010 | WO2010011853A3 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 07/22/2010 | WO2010007046A3 Heteroaryl derivatives as dgat1 inhibitors |
| 07/22/2010 | US20100184980 Process for Preparing 5-Fluoro-1H-Pyrazolo [3,4-b] Pyridin-3-amine and Derivatives Thereof |
| 07/22/2010 | US20100184977 Nickel or Iron Catalysed Carbon-Carbon Coupling Reaction of Arylenes, Alkenes and Alkines |
| 07/22/2010 | US20100184975 Compounds for alzheimber's disease |
| 07/22/2010 | US20100184973 Method for producing dioxazine derivatives |
| 07/22/2010 | US20100184805 Renin inhibitors |
| 07/22/2010 | US20100184802 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof |
| 07/22/2010 | US20100184791 Compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 07/22/2010 | US20100184788 Heterocyclic derivatives |
| 07/22/2010 | US20100184778 Novel heterocycle compounds and uses thereof |
| 07/22/2010 | US20100184777 Substituted Pyrazinone Amides |
| 07/22/2010 | US20100184772 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 07/22/2010 | US20100184765 Protein Kinase Inhibitors and Methods for Using Thereof |
| 07/22/2010 | US20100184764 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/22/2010 | US20100184763 Quinolone based compounds exhibiting, prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
| 07/22/2010 | US20100184762 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof |
| 07/22/2010 | US20100184754 Quinolinone derivatives |
| 07/22/2010 | US20100184753 Ion Channel Modulators and Methods of Uses |
| 07/22/2010 | US20100184750 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 07/22/2010 | US20100184747 Indoline derivatives and their use in treating disease-states such as cancer |
| 07/22/2010 | US20100184746 potent antimicrobial activity against macrolide resistant streptococcus pneumococci against which lincomycin and clindamycin are ineffective; therapeutic agents for infectious diseases in respiratory organs |
| 07/22/2010 | US20100184739 Modulators of ATP-Binding Cassette Transporters |
| 07/22/2010 | US20100184737 Imidazole compounds for the treatment of neurological disorders |
| 07/22/2010 | US20100184598 4-aza indole derivatives and their use as fungicides |
| 07/22/2010 | US20100183712 Acylated indanyl amines and their use as pharmaceuticals |
| 07/22/2010 | US20100183710 Omeprazole form b |
| 07/22/2010 | US20100183606 Monocyclic heterocycles as kinase inhibitors |
| 07/22/2010 | US20100183513 N-(methyl) -1h-pyrazol-3-amine, n-(methyl)-pyridin-2-amine and n-(methyl)-thiazol-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimer's |
| 07/22/2010 | US20100181900 Carbazole compounds and organo-electroluminescent devices using the same |
| 07/22/2010 | CA2749114A1 Heteroatom-containing cyclic compound |
| 07/21/2010 | EP2208727A1 Diaryl ethers as opioid receptor antagonist |
| 07/21/2010 | EP2208726A1 Cyclic amide derivatives, and their production and use as antithrombotic agents |
| 07/21/2010 | EP2208725A1 Novel specific inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications |
| 07/21/2010 | EP2207776A1 Drug active in neuropathic pain |
| 07/21/2010 | EP2207775A1 4-benzylamino-1-carboxyacyl-piperidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis |
| 07/21/2010 | EP2207774A1 Triazole derivatives as scd inhibitors |
| 07/21/2010 | EP2207773A2 Heterocyclic compound and pharmaceutical composition thereof |
| 07/21/2010 | EP2207549A1 Modulators of muscarinic receptors |
| 07/21/2010 | EP2207421A1 Haloalkylsubstituted aryloxyalkylimidazolines for use as pesticides |
| 07/21/2010 | EP1960390B1 Biaryl compounds useful as agonists of the gpr38 receptor |
| 07/21/2010 | EP1809622B1 Inhibitors of the interaction between mdm2 and p53 |
| 07/21/2010 | EP1636216B1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 07/21/2010 | EP1613621B1 Prostaglandin analogs as ep4 receptor agonists |
| 07/21/2010 | EP1487444B9 Use of pyridyl amides as inhibitors of angiogenesis |
| 07/21/2010 | EP1238977B2 Process for the preparation of a pyridinemethanol compound |
| 07/21/2010 | CN1960977B Quinazoline derivative |
| 07/21/2010 | CN101784545A Compounds useful as raf kinase inhibitors |
| 07/21/2010 | CN101784543A Indole and indazole compounds as an inhibitor of cellular necrosis |
| 07/21/2010 | CN101784539A 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors |
| 07/21/2010 | CN101784538A Pyridoneamide derivatives as focal adhesion kinase (FAK) inhibitors and their use for the treatment of cancer |
| 07/21/2010 | CN101784537A Process for production of hydrazine compound, intermediate for production of hydrazine compound, and process for production of the intermediate |
| 07/21/2010 | CN101784533A 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy |
| 07/21/2010 | CN101784532A Novel HIV reverse transcriptase inhibitors |
| 07/21/2010 | CN101784530A 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors |
| 07/21/2010 | CN101784528A Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof |
| 07/21/2010 | CN101784523A Novel compounds, compounds that influence cellular vesicular systems, pharmaceutical compositions, and use thereof |
| 07/21/2010 | CN101784515A Pyridinecarboxamide and benzamide derivatives as taar1 ligands |
| 07/21/2010 | CN101784276A Use of compounds for preparing anti-tuberculosis agents |
| 07/21/2010 | CN101781313A Method for synthesizing quinolone medicaments |
| 07/21/2010 | CN101781299A One-pot synthesis method for key intermediate of carbostyril medicaments |
| 07/21/2010 | CN101781291A 1,5-disubstituted hexahydrotriazine-2-N-nitroimine derivative |
| 07/21/2010 | CN101781285A Quinazoline derivates, preparation method thereof and pharmaceutical application thereof |
| 07/21/2010 | CN101781284A Method for purifying 2-[N-(2-methyl-5-nitrophenyl)amino]-4-(3-pyridyl)pyrimidine |
| 07/21/2010 | CN101781263A Nitrogen methyl side chain-substituted triadimenol antifungal compound and preparation method thereof |
| 07/21/2010 | CN101781262A Method for preparing 4-aryl-1H-1,2,3-triazole |
| 07/21/2010 | CN101407493B Organic material and use thereof in organic EL device |
| 07/20/2010 | US7759499 used for the treatment or prevention of HCV or amelioration the symptoms of hepatitis C infection, by modulating the interaction of an HCV polypeptide with HCV proteases |
| 07/20/2010 | US7759392 4-nitroxybutyric acid ester derivatives of drugs such as acetaminophen, having an improved therapeutic index (efficacy/toxicity ratio) or a lower risk/benefit ratio, usedfor treating oxidative stress and endothelian dysfunctions, inflammation and pain |
| 07/20/2010 | US7759387 such as (4-{2-[5-Carbamimidoyl-1-oxo-1,3-dihydro-isoindol-2-yl]-acetyl}-phenoxy)-acetic acid methyl ester, used for inhibiting the binding of fibrinogen to blood platelets, platelet aggregation and for the treatment of thrombotic diseases |
| 07/20/2010 | US7759385 opioid receptor ligands such as {4-[3-(1H-indol-3-yl)-pyrrolidine-1-yl]-1-phenyl-cyclohexyl}-dimethylamine dihydrochloride salt, used as analgesics |
| 07/20/2010 | US7759380 Substituted pyrrolines as kinase inhibitors |
| 07/20/2010 | US7759379 Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 07/20/2010 | US7759373 nitrogen-containing 5-membered heterocyclic compound |
| 07/20/2010 | US7759372 benzimidazole derivatives having antiviral activities, used optionally in combination with a polymerase inhibitor and/or a protease inhibitor |
| 07/20/2010 | US7759367 Pharmaceutical compositions and their uses |
| 07/20/2010 | US7759366 4-[4,4-Dimethyl-2,5-dioxo-3-(2-phenylaminobenzyl)imidazolidin-1-yl]-2-trifluoromethylbenzonitrile, used for treating syndrome X, diabetes, obesity, drug abuse and dependence, schizophrenia, Alzheimer's disease, polycystic ovary syndrome and as dietetics |
| 07/20/2010 | US7759356 administering adenosine receptors antagonists, such as 2-amino-4-phenyl-indeno[1,2-d]pyrimidin-5-one, for the treatment of neurodegenerative diseases; Parkinson's Disease |
| 07/20/2010 | US7759343 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 07/20/2010 | US7759336 chemokine receptor antagonists such as N-(4-azepan-1-ylpyrimidin-2-yl)ethane-1,2-diamine, used for the treatment and prevention of inflammatory diseases, allergic diseases, acquired immunodeficiency syndrome infection with human immunodeficiency virus |
| 07/20/2010 | CA2595569C Substituted triazole derivatives as oxytocin antagonists |
| 07/20/2010 | CA2539297C Substituted triazole derivatives as oxytocin antagonists |
| 07/20/2010 | CA2502416C N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents |
| 07/20/2010 | CA2486399C Calcium receptor modulating agents |
| 07/20/2010 | CA2447865C Novel sulfonic acid derivatives |
| 07/20/2010 | CA2431982C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 07/20/2010 | CA2428237C Process for the preparation of carbostyril derivatives |
| 07/20/2010 | CA2407866C Process for the synthesis of amine ethers from secondary amino oxides |
| 07/20/2010 | CA2399001C Integrin expression inhibitor |
| 07/20/2010 | CA2290136C New erythromycin derivatives, the process for preparing them and their use as a drug product |
| 07/17/2010 | WO2010067131A1 P38 map kinase inhibitors |
| 07/15/2010 | WO2010080481A1 Carbazole carboxamide compounds useful as kinase inhibitors |
| 07/15/2010 | WO2010080474A1 Carbazole and carboline kinase inhibitors |
| 07/15/2010 | WO2010080472A1 Electron-transporting materials comprising and processes for making the same |
| 07/15/2010 | WO2010080471A1 2,4,6-tri-(heteroarylphenyl)-pyridines and electron-transporting materials comprising them |
| 07/15/2010 | WO2010080357A1 Serotonin 5-ht2b receptor inhibitors |
| 07/15/2010 | WO2010079504A2 Stable r(+)-lansoprazole amine salt and a process for preparing the same |
| 07/15/2010 | WO2010078906A2 Hydrazides method for production and use thereof as herbicide and insecticide |